Island Pharmaceuticals
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
697 Burke Rd Se 201, Camberwell, Victori...Phone Number
+61 390920475Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Island Pharmaceuticals
Island Pharmaceuticals is a clinical-stage drug repurposing company focused on developing antiviral therapeutics for infectious diseases. The company specializes in research and development within the pharmaceutical industry, with its primary asset being ISLA-101, a drug being repurposed for the prevention and treatment of dengue fever and other mosquito-borne diseases. Island Pharmaceuticals is advancing clinical trials for dengue-infected subjects and may be eligible for a Priority Review Voucher upon FDA approval, which could expedite future drug approvals or be sold in secondary markets. The company operates primarily in the business-to-business sector, providing innovative pharmaceutical solutions through scientific research and clinical development.Explore more
Island Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Island Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Island Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Island Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Island Pharmaceuticals had a recent Job posting/layoffs
Check out if Island Pharmaceuticals is spiking on competitors!
Check if Island Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Island Pharmaceuticals
Earning: See what the market has to say on Island Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Island Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Island Pharmaceuticals
Compare insights from companies similar to Island Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Island Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Island Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Island Pharmaceuticals.
Island Pharmaceuticals financials insights
Gather financial insights about Island Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$2.7M
Stock/Share Issuance
$350K
Island Pharmaceuticals Tech Stack
A closer look at the technologies used by Island Pharmaceuticals
Most Recent Scoops
Person-Based
Research & Development, Pharmaceuticals
Person-Based
Pharmaceuticals, Public Health
Funding
Island Pharmaceuticals has secured $350,000 in Share Issuance funding. Investors were not disclosed.
Funding
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Island Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Island Pharmaceuticals is a clinical-stage drug repurposing company focused on developing antiviral therapeutics for infectious diseases. The company specializes in research and development within the pharmaceutical industry, with its primary asset being ISLA-101, a drug being repurposed for the prevention and treatment of dengue fever and other mo... Read More
